Please be sure to acknowledge your affiliation with the PIIO in future posters, publications and seminar presentations. The PIIO also encourages its members to advertise their affiliation on their research lab websites. Acknowledgement of PIIO affiliation is crucial to displaying the Institute’s impact to our donors and the research community.
Recommended text
Statement:
“This work was supported by the Pelotonia Institute of Immuno-Oncology (PIIO). The content is solely the responsibility of the authors and does not necessarily represent the official views of the PIIO.”
Affiliation:
Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA.
- Abbreviated: Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA.
- Further abbreviated: Pelotonia Institute for Immuno-Oncology, OSUCCC – James, The Ohio State University, Columbus, OH 43210, USA.
Text and URL for Listing PIIO on your Research Lab Website:
- Text: The OSUCCC - James, Pelotonia Institute for Immuno-Oncology
- URL: https://cancer.osu.edu/for-cancer-researchers/research/research-institutes-and-centers/pelotonia-institute-for-immuno-oncology
Research Supported by the IMDP:
Research reported in this publication was supported by The Ohio State University Comprehensive Cancer Center (OSUCCC) and the National Institutes of Health (NIH) under grant P30CA016058. This research was made possible through resources, expertise, and support provided by the Pelotonia Institute for Immuno-Oncology (PIIO), which is funded by the Pelotonia community and the OSUCCC. We thank the PIIO and the Immune Monitoring and Discovery Platform for [describe contributions here]. We thank the [name SR] Shared Resource at the OSUCCC for [describe contribution here].